|
|
|
|
| LEADER |
03390nam a2200517 4500 |
| 001 |
978-3-030-31000-4 |
| 003 |
DE-He213 |
| 005 |
20191022021011.0 |
| 007 |
cr nn 008mamaa |
| 008 |
190924s2019 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783030310004
|9 978-3-030-31000-4
|
| 024 |
7 |
|
|a 10.1007/978-3-030-31000-4
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a R856-R857
|
| 072 |
|
7 |
|a MQW
|2 bicssc
|
| 072 |
|
7 |
|a MED003040
|2 bisacsh
|
| 072 |
|
7 |
|a MQW
|2 thema
|
| 082 |
0 |
4 |
|a 610.28
|2 23
|
| 100 |
1 |
|
|a Koo, Kevin M.
|e author.
|4 aut
|4 http://id.loc.gov/vocabulary/relators/aut
|
| 245 |
1 |
0 |
|a Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics
|h [electronic resource] /
|c by Kevin M. Koo.
|
| 250 |
|
|
|a 1st ed. 2019.
|
| 264 |
|
1 |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2019.
|
| 300 |
|
|
|a XIII, 102 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Springer Theses, Recognizing Outstanding Ph.D. Research,
|x 2190-5053
|
| 505 |
0 |
|
|a Unifying Next-Generation Biomarkers and Nanodiagnostic Platforms for Precision Prostate Cancer (PCa) Management -- Colorimetric Gene Fusion Diagnostics for Visual Binary Readout -- Label -Free Surface-Enhanced Raman Scattering Detection System for Clinical Biomarker Targets -- Amplification-Free Electrochemical RNA Biomarker Sensing -- Simultaneous Analysis of Multiple Biomarkers via High-Throughput Parallel Profiling.
|
| 520 |
|
|
|a This book presents a unique concept of merging nanotechnology and novel urinary biomarkers for accurate early prostate cancer detection, discussing an entire progressive pipeline of innovative new strategies in biosensor development, from a simple colorimetric system to a complex system for simultaneous multiple biomarker sensing. For newcomers to the field of nucleic acid biosensing, it also describes various isothermal amplification and amplification-free strategies, which are currently the main research areas. Lastly, the book introduces and demonstrates the notion of clinical nanobiosensor validation toward clinical translation: the ultimate aim of researchers in the biosensor field. This book is a valuable reference resource learners seeking inspiration for cancer biosensor development.
|
| 650 |
|
0 |
|a Biomedical engineering.
|
| 650 |
|
0 |
|a Nanotechnology.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
1 |
4 |
|a Biomedical Engineering/Biotechnology.
|0 http://scigraph.springernature.com/things/product-market-codes/B24000
|
| 650 |
2 |
4 |
|a Nanotechnology.
|0 http://scigraph.springernature.com/things/product-market-codes/Z14000
|
| 650 |
2 |
4 |
|a Biomedical Engineering and Bioengineering.
|0 http://scigraph.springernature.com/things/product-market-codes/T2700X
|
| 650 |
2 |
4 |
|a Cancer Research.
|0 http://scigraph.springernature.com/things/product-market-codes/B11001
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030309992
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030310011
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783030310028
|
| 830 |
|
0 |
|a Springer Theses, Recognizing Outstanding Ph.D. Research,
|x 2190-5053
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-030-31000-4
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
